Interferon alpha and 5′-deoxy-5-fluorouridine in colon cancer: Effects as single agents and in combination on growth of xenograft tumours
- 31 December 1994
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 30 (12), 1859-1865
- https://doi.org/10.1016/0959-8049(94)00341-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancerEuropean Journal Of Cancer, 1993
- Interactions of interferon-α2a with 5′-deoxy-5-fluorouridine in colorectal cancer cells in vitroEuropean Journal Of Cancer, 1992
- Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cellsBiochemical and Biophysical Research Communications, 1992
- Phase II clinical trial of doxifluridine in patients with advanced ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Comparative Antitumor Activity and Intestinal Toxicity of 5′-Deoxy-5-fluorouridine and Its Prodrug Trimethoxybenzoyl-5′-deoxy-5-fluorocytidineJapanese Journal of Cancer Research, 1990
- Phase I study of oral doxifluridine using two schedulesEuropean Journal of Cancer and Clinical Oncology, 1989
- Comparison of the pyrimidine nucleoside phosphorylase activity in human tumors and normal tissuesExperimental pathology, 1988
- Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridineEuropean Journal of Cancer (1965), 1980
- Complete replacement of serum in primary cultures of erythropoietin-dependent red cell precursors (CFU-E) by albumin, transferrin, iron, unsaturated fatty acid, lecithin and cholesterolExperimental Cell Research, 1980
- ‘Nude’, a new hairless gene with pleiotropic effects in the mouseGenetics Research, 1966